A proteomic analysis of Bcl-2 regulation of cell cycle arrest: insight into the mechanisms

Abstract

B cell lymphoma 2 (Bcl-2) is an important antiapoptotic gene that plays a dual role in the maintenance of the dynamic balance between the survival and death of cancer cells. In our previous study, Bcl-2 was shown to delay the G0/G1 to S phase entry by regulating the mitochondrial metabolic pathways to produce lower levels of adenosine triphosphate (ATP) and reactive oxygen species (ROS). However, the detailed molecular mechanisms or pathways by which Bcl-2 regulates the cell cycle remain unknown. Here, we compared the effects of Bcl-2 overexpression with an empty vector control in the NIH3T3 cell line synchronized by serum starvation, and evaluated the effects using proteomic analysis. The effect of Bcl-2 on cell cycle regulation was detected by monitoring Bcl-2 and p27 expression. The result of subsequent proteomic analysis of Bcl-2 overexpressing cells identified 169 upregulated and 120 downregulated proteins with a 1.5-fold change. These differentially expressed proteins were enriched in a number of signaling pathways predominantly involving the ribosome and oxidative phosphorylation, according to the data of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. These results indicated that Bcl-2 potentially acts at the translation level to influence proteins or enzymes of the respiratory chain or in the ribosome, and thereby regulates the cell cycle. Additionally, differentially expressed proteins involved in oxidative phosphorylation were determined to account for most of the effects of Bcl-2 on the cell cycle mediated by the mitochondrial pathway investigated in our previous study. These results can provide assistance for additional in-depth studies on the regulation of the cell cycle by Bcl-2. The results of the proteomic analysis determined the mechanism of Bcl-2dependent delay of the cell cycle progression. In summary, the results of this study provide a novel mechanistic basis for identifying the key proteins or pathways for designing and developing precisely targeted cancer drugs.

Caloric Restriction Mitigates Kidney Fibrosis in an Aged and Obese Rat Model

“…Our present findings showed that CR inhibit the pro-apoptotic proteins BAX, pJNK and Caspase 3 by enhancing BCL-2 expression. However, this last result is also in according with evidence from the literature that highlight a non-apoptotic role of Bcl-2 related to an inhibitory effect on the cell cycle depending on a cyclin/cyclin-dependent kinase (CDK) inhibitor p27 [70][71][72]. In agreement with these observations our results showed that Bcl-2 overexpression in OA vs Y group, results in elevated levels of p27 protein.…”

In-silico characterization of LSDV132 protein divulged its BCL-2-like nature

“…The results of KEGG analysis revealed that this protein possessed Poxvirus-BCL-2-like motifs, thus, it might be involved in immunomodulation of apoptosis in host cells. The infected cells embody the apoptotic cell death to evade the spread of viruses to the neighboring cells [ 40 ]. To avoid this evasion, the viral BCL-2 protein regulates this activity in the individual host, accordingly.…”

Benzo[b]fluoranthene induced oxidative stress and apoptosis in human airway epithelial cells via mitochondrial disruption

“…Once activated, caspase‐9 cleaves and activates the effector caspases‐3 to bring about apoptosis (Araya et al, 2021). Bcl‐2 is an important anti‐apoptotic biomarker that plays a dual role in maintaining the dynamic balance between cell survival and death (Du et al, 2021; Mazel et al, 1996). Bax is a gene that regulates the apoptotic pathway, and we report an increased Bax/Bcl‐2 ratio following BbF treatment, suggesting that apoptosis is favored in BEAS‐2B and 16HBE cells (Shi et al, 2015).…”